Effective June 19, the Board of Pharmacy had published a final rule amending regulations under OAR 855-019 to allow any person, having once lawfully obtained naloxone, to possess, distribute or administer it for the purpose of reversing an opiate overdose. The rule also requires oral counseling on the use of naloxone be offered by pharmacists rather than require that such counseling be provided.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Oregon Health Authority (OHA) issued a notice to Medicaid pharmacy providers on May 25 regarding the requirement that prescribers (including those administering immunizations) register with the OHA by Saturday, September 1.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy confirmed three chain pharmacy industry representatives have been selected from among a slate of industry candidates for the 11-member Rules Advisory Committee (RAC) that will consider revisions to proposed rules that would require all supervisors of Oregon pharmacists-in-charge (PICs) to be Oregon-licensed pharmacists and would give PICs carte blanch over the pharmacy operations without regard to company policy. The RAC will hold its first meeting June 29 from 1:15 p.m.-3:15 p.m. PDT in Portland.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Under the law allowing pharmacies to dispense naloxone in the state, there is a requirement that the information about the naloxone prescription must be reported to the state’s prescription drug monitoring program, just as pharmacies do with all controlled substances prescriptions. Concern has been expressed to the Board of Pharmacy by the Health Care Authority that pharmacies are not in compliance with this reporting requirement. Subsequently, the Board sent a reminder to pharmacies.
Also in Oregon…The first meeting of the Rules Advisory Committee to discuss proposed rules that would require all supervisors of Oregon pharmacists-in-charge (PICs) to be Oregon-licensed pharmacists and would give PICs carte blanch over the pharmacy operations without regard to company policy will be held Thursday, May 24 at the Board of Pharmacy’s office in Portland. The public is welcome to attend.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.